Table 2.

Select white blood cell differentials between groups over the training intervention

Group	Bout	WBC (103/μL)	Neutrophil Percent	Neutrophil Count (103/μL)	Lymphocyte Percent	Lymphocyte Count (103/μL)	Monocyte Percent	Monocyte Count (103/μL)
BCAA-CHO	T1	6.51 ± 0.35	55.46 ± 2.45	3.64 ± 0.28	34.06 ± 2.41	2.03 ± 0.13	7.18 ± 0.32	0.49 ± 0.04
	24 h post bout 1	6.19 ± 0.26	56.77 ± 1.96	3.52 ± 0.21	31.79 ± 1.38	2.04 ± 0.15	7.48 ± 0.33	0.47 ± 0.03
	24 h post bout 2	6.43 ± 0.26	58.35 ± 2.51	3.97 ± 0.31	32.11 ± 2.33	1.89 ± 0.19	6.86 ± 0.31	0.44 ± 0.03
	48 h post bout 3 (T2)	6.56 ± 0.37	57.26 ± 1.81	3.69 ± 0.29	31.21 ± 1.90	1.98 ± 0.10	7.25 ± 0.24	0.49 ± 0.03
CHO	T1	6.44 ± 0.35	55.43 ± 2.59	3.53 ± 0.29	32.61 ± 2.03	2.11 ± 0.12	8.21 ± 0.45	0.57 ± 0.03
	24 h post bout 1	5.85 ± 0.32	53.54 ± 2.24	3.20 ± 0.28	32.43 ± 2.35	1.91 ± 0.12	8.75 ± 0.52 ‡	0.50 ± 0.03
	24 h post bout 2	5.81 ± 0.33	53.18 ± 2.92	3.05 ± 0.28	33.76 ± 2.79	1.90 ± 0.13	9.16 ± 0.40 ‡	0.55 ± 0.03
	48 h post bout 3 (T2)	6.21 ± 0.32	53.15 ± 2.06	3.34 ± 0.24	30.37 ± 2.14	1.90 ± 0.12	9.15 ± 0.38 ‡†	0.59 ± 0.03

Abbreviations BCAA-CHO branched-chain amino acid and carbohydrate-supplemented group, CHO carbohydrate only-supplemented group

Analysis of monocyte percentages revealed a group*time interaction (p = 0.01) whereby BCAA-CHO supplementation attenuated increases in monocyte percentages 24 h following bout 1 (p = 0.049), 24 h following bout 2 (p < 0.001), and 48 h following bout 3 (or at T2; p < 0.001) compared to CHO supplementation (denoted by bold lettering and superscript ‡ symbol). Moreover, T2 monocyte percentages increased within the CHO group at T2 compared to T1 (denoted by superscript † symbol, p = 0.012)